Regimen Switching After Initial Haart By Race in a Military Cohort
نویسندگان
چکیده
RESEARCH ARTICLE Regimen Switching After Initial Haart By Race in a Military Cohort Christina Schofield, Xun Wang, Patrick Monahan, Xiuping Chu, Margaret Glancey, Anuradha Ganesan, Jason F. Okulicz and Brian K. Agan Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, USA Madigan Army Medical Center, Tacoma, WA, USA Air Force Medical Operations Agency, San Antonio, TX, USA San Antonio Military Medical Center, San Antonio, TX, USA Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA
منابع مشابه
The effects of setarud on the immunological status of HIV-positive patients: Efficacy of a novel multi-herbal drug
Objective: This study examines the effect of the addition of IMOD, a novel multi-herbal drug to the highly active anti-retroviral therapy (HAART) regimen, on the immunological status of HIV-positive patients. Materials and Methods: A randomized two-parallel-group (HAART group versus HAART+IMOD group), pretest-posttest design was used.Sixty patients with indications for treatment with the HAART ...
متن کاملRace/ethnicity and HAART initiation in a military HIV infected cohort
BACKGROUND Prior studies have suggested that HAART initiation may vary by race/ethnicity. Utilizing the U.S. military healthcare system, which minimizes confounding from healthcare access, we analyzed whether timing of HAART initiation and the appropriate initiation of primary prophylaxis among those at high risk for pneumocystis pneumonia (PCP) varies by race/ethnicity. METHODS Participants ...
متن کاملInjection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts
BACKGROUND Sustained use of antiretroviral therapy has been consistently shown to be one of the primary predictors of long-term effectiveness. Switching and discontinuation reflect patient and provider decisions that may limit future treatment options. In this study, we utilize data reported at semi-annual study visits from three prospective cohort studies, the AIDS Link to IntraVenous Exposure...
متن کاملRates and Reasons for Early Change of First HAART in HIV-1-Infected Patients in 7 Sites throughout the Caribbean and Latin America
BACKGROUND HAART rollout in Latin America and the Caribbean has increased from approximately 210,000 in 2003 to 390,000 patients in 2007, covering 62% (51%-70%) of eligible patients, with considerable variation among countries. No multi-cohort study has examined rates of and reasons for change of initial HAART in this region. METHODOLOGY Antiretroviral-naïve patients >or= 18 years who started...
متن کاملClinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen
BACKGROUND Raltegravir is the first integrase inhibitor approved for treatment of HIV-infected patients harboring multiresistant viruses. METHODS From a Danish population-based nationwide cohort of HIV patients we identified the individuals who initiated a salvage regimen including raltegravir and a matched cohort of HIV-infected patients initiating HAART for the first time. We compared these...
متن کامل